Sabiedrība ar ierobežotu atbildību "Inpharmatis Group"Active
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedNo dividends were paid.
Summary of financial statements2013–2025
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||||||
| Total current assets | 2820 | 8108 | 6218 | 30 229 | 80 463 | 40 685 | 148 237 | 624 658 | 1 071 676 | 955 518 | 986 692 | 786 999 | 131 291 |
| Total non-current assets | 0 | 4199 | 9599 | 8455 | 10 717 | 43 195 | 20 460 | 325 | 5513 | 1895 | 877 | 1607 | 7664 |
| Total assets | 2820 | 12 307 | 15 817 | 38 684 | 91 180 | 83 880 | 168 697 | 624 983 | 1 077 189 | 957 413 | 987 569 | 788 606 | 138 955 |
| Balance sheet — liabilities and equity | |||||||||||||
| Current liabilities | 6276 | 7546 | 43 691 | 0 | 501 986 | 284 557 | 225 921 | 628 453 | 551 238 | 933 086 | 917 532 | 433 783 | 613 185 |
| Non-current liabilities | 0 | 0 | 0 | 167 178 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 6276 | 7546 | 43 691 | 167 178 | 501 986 | 284 557 | 225 921 | 628 453 | 551 238 | 933 086 | 917 532 | 433 783 | 613 185 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | -5456 | 9678 | -32 635 | -100 620 | -282 311 | 210 129 | 143 453 | 53 772 | 529 421 | 21 499 | 67 209 | -259 836 | -829 053 |
| Total equity | -3456 | 4761 | -27 874 | -128 494 | -410 806 | -200 677 | -57 224 | -3470 | 525 951 | 24 327 | 70 037 | 354 823 | -474 230 |
| Income statement | |||||||||||||
| Sales revenue | 8976 | 45 659 | 55 033 | 84 935 | 244 622 | 777 280 | 408 818 | 435 812 | 2 213 616 | 627 052 | 383 978 | 294 102 | 100 390 |
| Operating profit | -5426 | 10 242 | -32 012 | -100 174 | -282 316 | 147 152 | 146 934 | 54 702 | 529 421 | -8394 | 31 645 | -285 146 | -836 075 |
| Profit before income tax | -5456 | 9970 | -32 635 | -100 620 | -282 311 | 213 273 | 146 934 | 54 702 | 529 421 | 21 511 | 67 209 | -259 836 | -829 053 |
| Profit for the reporting year | -5456 | 9678 | -32 635 | -100 620 | -282 311 | 210 129 | 143 453 | 53 772 | 529 421 | 21 499 | 67 209 | -259 836 | -829 053 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | |||||||||||||
| Employees | 1 | 1 | 3 | 8 | 10 | 5 | 2 | 2 | 6 | 7 | 7 | 12 | 13 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 523 123 | 21 499 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
Summary: Sabiedrība ar ierobežotu atbildību "Inpharmatis Group"
Overview
Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" (reg. no. 40103675920) is a limited liability company. The company was registered in 2013 and has been in the register for 13 years. Registered address: Rīga, Ģertrūdes iela 7.
Financial results
Revenue in 2025 was 100 390 €, down 65,9% on the previous year (294 102 €). From 2013 to 2025, revenue grew by an average of 22,3% per year. 2025 ended with a loss of 829 053 €. The company was profitable in 7 of the 13 published years. In 2025 the company had 13 employees (12 a year earlier). Revenue per employee was 7722 €.
Management and owners
The company has one board member. The sole owner of the company is a private individual.
Points to note
Equity was negative at the end of 2025 (-474 230 €).
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.